C.N. Chesterman
- Rheumatology top 0.5%
- Hematology top 1%
- Radiology, Nuclear Medicine and Imaging top 2%
- Immunology top 5%
- Molecular Biology
- Co-authors
- H. Patrick McNeilSteven A. KrilisRichard J. SimpsonBeng H. ChongLevon M. KhachigianD. OwensbyPhilip J. HoggMichael C. Berndt
- Topics
- Platelet Disorders and Treatments (12 papers)Venous Thromboembolism Diagnosis and Management (8 papers)Protease and Inhibitor Mechanisms (7 papers)
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
C.N. Chesterman
39 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Rheumatology 1.3k
- Hematology 1000
- Radiology, Nuclear Medicine and Imaging 576
- Immunology 467
- Molecular Biology 459
Countries citing papers authored by C.N. Chesterman
This map shows the geographic impact of C.N. Chesterman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.N. Chesterman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.N. Chesterman more than expected).
Fields of papers citing papers by C.N. Chesterman
This network shows the impact of papers produced by C.N. Chesterman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.N. Chesterman. The network helps show where C.N. Chesterman may publish in the future.
Co-authorship network of co-authors of C.N. Chesterman
This figure shows the co-authorship network connecting the top 25 collaborators of C.N. Chesterman. A scholar is included among the top collaborators of C.N. Chesterman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.N. Chesterman. C.N. Chesterman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 106 | |
| 2 | 0 | |
| 3 | 33 | |
| 4 | 41 | |
| 5 | 6 | |
| 6 | 21 | |
| 7 | 10 | |
| 8 | 20 | |
| 9 | 173 | |
| 10 | 153 | |
| 11 | Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).breakdown → | 1299 |
| 12 | 35 | |
| 13 | 25 | |
| 14 | 24 | |
| 15 | 9 | |
| 16 | 9 | |
| 17 | 17 | |
| 18 | 23 | |
| 19 | The survival of glucose-6-phosphate dehydrogenase--deficient erythrocytes in patients with typhoid fever on chloramphenicol therapy. | 15 |
| 20 | 18 |
About C.N. Chesterman
C.N. Chesterman is a scholar working on Internal Medicine, Hematology and Immunology and Allergy, having authored 40 papers that have together received 2.6k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (12 papers), Venous Thromboembolism Diagnosis and Management (8 papers) and Protease and Inhibitor Mechanisms (7 papers). The work is most often cited by research in Hematology (1000 citations), Rheumatology (1.3k citations) and Internal Medicine (216 citations). C.N. Chesterman has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include H. Patrick McNeil, Steven A. Krilis, Richard J. Simpson, Beng H. Chong, Levon M. Khachigian, D. Owensby, Philip J. Hogg, Michael C. Berndt, Michael P. Skinner and Gordon F. Burns. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.